OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,074,229 | -31.1% | 342,111 | +13.2% | 0.03% | -44.9% |
Q2 2023 | $1,558,893 | -18.6% | 302,111 | -16.8% | 0.05% | -16.9% |
Q1 2023 | $1,914,517 | -99.8% | 363,286 | +62.9% | 0.06% | +227.8% |
Q3 2022 | $926,000,000 | -55.1% | 223,066 | -56.5% | 0.02% | -40.0% |
Q2 2022 | $2,062,000,000 | – | 512,886 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |